A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND SHATAVARYADI KWATHA IN PITTAJA MUTRAKRICCHRA

Phase 2/3

Not yet recruiting

• Conditions: Urinary tract infection, site notspecified. Ayurveda Condition: PITTAJAMUTRAKRUCCRAM,

• Registration Number: CTRI/2021/11/037733
• Lead Sponsor: MURALIDHAR A MIRAJKAR

Brief Summary

THIS IS A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND SHATAVARYADI KWATHA IN PAITTIKA MUTRAKRICCHRA FOR DURATION OF 7 DAYS IN 60 PATIENTS IN OPD AND IPD OF PG STUDIES IN KAYACHIKITSA OF ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL MOODBIDRI VIDYAGIRI DAKSHINA KANNADA KARNATAKA INDIA

ASSESSMENT WILL BE DONE BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE AND OBJECTIVE PARAMETERS

PRE AND POST ASSESSMENT WILL BE DONE CLINICAL SYMPTOMS WILL BE GRADED AND SCORES WILL BE GIVEN ACCORDINGLY

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-11
• Last Update Posted: 2021-10-29

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patient within the age group of 16-60 years, who will give their written consent, who will agree to follow the protocol of study.
• Patients with classical symptoms of pittaja mutrakricchra like peeta mutrata, sarakta mutrata, daaha mutrata, rujayukta mutrata and muhur mutrata.

Exclusion Criteria

• Paittika mutrakricchra caused due to marmabhighata, due to congenital deformity, due to STD.
• Vulnerable groups like pregnant women, lactating mother.
• Patients with other systemic disorders like diabetes mellitus, thyroid disorders, cardiac illness and other disorders which interfere with the treatment.
• Secondary to disorders like Asthma, BPH, acute renal failure, vesico-ureteric reflux, tumor, renal tuberculosis.
• Patients who are not willing to consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
THE EFFECT OF THE TREATMENT WILL BE ASSESSED BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE PARAMETERS SUCH AS PAINFUL MICTURITION BURNING MICTURITION DIFFICULTY IN MICTURITION FREQUENCY OF MICTURITION NOCTURIA AND OBJECTIVE PARAMETERS SUCH AS YELLOW COLORATION OF URINE HEMATURIA PUS CELLS/HPF EPITHELIAL CELLS/HPF RBCS/HPF. PRE AND POST INTERVENTIONAL ASSESSMENT WILL BE DONE.	AT BASELINE 4TH DAY 8TH DAY AND 15TH DAY

Trial Locations

Locations (1)

ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL; 🇮🇳 Kannada, KARNATAKA, India

ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL

🇮🇳Kannada, KARNATAKA, India

DR MEGHA MIRAJKAR

Principal investigator

8792111380

meghmm03@gmail.com